CervoMed (NASDAQ:CRVO) Price Target Raised to $15.00
CervoMed (NASDAQ:CRVO – Get Free Report) had its price target hoisted by equities researchers at Chardan Capital from $14.00 to $15.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Chardan Capital’s price objective indicates a potential upside of 72.41% from the stock’s current price. CRVO […]
CervoMed (NASDAQ:CRVO – Get Free Report) had its price target hoisted by equities researchers at Chardan Capital from $14.00 to $15.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Chardan Capital’s price objective indicates a potential upside of 72.41% from the stock’s current price. CRVO […]
